Information  X 
Enter a valid email address

Celtic PLC (CCP)

  Print          Annual reports

Tuesday 31 August, 2021

Celtic PLC

Issue of Equity

RNS Number : 2124K
Celtic PLC
31 August 2021
 

CELTIC PLC

Issued share capital

 

As a result of the conversion of 500 Convertible Cumulative Preference Shares of 60p each on 27 August 2021 and of the issue of 35,938 Ordinary Shares of 1p each under the Company's scrip dividend reinvestment scheme on 31 August 2021, Celtic PLC's issued share capital as at 31 August 2021 was as follows:

 

 

94,457,071

Ordinary Shares of 1p each ("Ordinary Shares") 

12,734,432

Convertible Preferred Ordinary Shares of 100p each ("CPO Shares")

15,797,424

Convertible Cumulative Preference Shares of 60p each ("CCP Shares")

676,275,323

Deferred Shares of 1p each ("Deferred Shares")

 

CCP Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights. 

 

The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure Guidance and Transparency Rules.

 

The new Ordinary Shares of 1p each allotted under the scrip scheme have been issued at a notional price of 111p each.

 

Application has been made for the admission of the 36,438 new Ordinary Shares of 1p each arising from these conversions ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, will commence on 7 September 2021.

 

Enquiries:

 

Company

Michael Nicholson, Company Secretary    0141 551 4298

 

Canaccord Genuity Limited

Simon Bridges, Nominated Adviser                                       020 7523 8350

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEVFLBXFVLZBBX

a d v e r t i s e m e n t